Exogenous IL‐10 posttreatment along with TLR4 and TNFR1 blockade improves tissue antioxidant status by modulating sepsis‐induced macrophage polarization

Abstract Multi‐organ dysfunction is one of the major reasons behind the high mortality of sepsis throughout the world. With the pathophysiology of sepsis remaining largely unknown, the uncontrolled reactive oxygen species (ROS) production along with the decreased antioxidants contributes to the progression toward septic shock. Being the effector cells of the innate immunity system, macrophages secrete both pro‐inflammatory and anti‐inflammatory mediators during inflammation. Lipopolysaccharide (LPS) binding to toll‐like receptor 4 (TLR4) releases TNF‐α, which initiates pro‐inflammatory events through tumor necrosis factor receptor 1 (TNFR1) signaling. However, it is counteracted by the anti‐inflammatory interleukin 10 (IL‐10) causing decreased oxidative stress. Our study thus aimed to assess the effects of exogenous IL‐10 treatment post‐neutralization of TLR4 and TNFR1 (by anti‐TLR4 antibody and anti‐TNFR1 antibody, respectively) in an in vivo murine model of LPS‐sepsis. We have also examined the tissue‐specific antioxidant status in the spleen, liver, and lungs along with the serum cytokine levels in adult male Swiss albino mice to determine the functional association with the disease. The results showed that administration of recombinant IL‐10 post‐neutralization of the receptors was beneficial in shifting the macrophage polarization to the anti‐inflammatory M2 phenotype. IL‐10 treatment significantly downregulated the free radicals production resulting in diminished lipid peroxidase (LPO) levels. The increased antioxidant activities of superoxide dismutase (SOD), catalase (CAT), and glutathione reductase (GR X ) conferred protection against LPS‐induced sepsis. Western blot data further confirmed diminished expressions of TLR4 and TNFR1 along with suppressed stress‐activated protein kinases/Jun amino‐terminal kinases (SAPK/JNK) and increased SOD and CAT expressions, which altogether indicated that neutralization of TLR4 and TNFR1 along with IL‐10 posttreatment might be a potential therapeutic measure for the treatment of sepsis.